1.
Clinical impact of a direct Rapid Antimicrobial Susceptibility Testing (dRAST) in administration of optimal therapy in patients with bloodstream infection ; Belgique
2.
Surveillance of antimicrobial resistance in Streptococcus agalactiae isolated from patients in Belgium (1989-1991 versus 1996-1999)
3.
4.
5.
Evolution of antimicrobial susceptibility patterns of clinical group B streptococci isolated in Belgium
Antimicrobial Susceptibilities of recent clinical isolates of group B streptococci agalactiae from Belgium
Susceptibility profile to penicillin, erythromycin and clindamycin of clinical isolates of grup B streptococci recently isolated in Belgium and detection of erythromycin resistance...
Surveillance of serotypes and antimicrobial susceptibility profile in group B streptococcus (GBS) in Belgium
Update of the characteristics of Group B Streptococci (GBS) colonizing pregnant women in Belgium: capsular-type distribution, pili characterization, antimicrobial susceptibility pr...